Coinbase Global enters July with a bruising week behind it and a setup that has grown more complicated since the June 24 note: short interest has reversed its prior decline, options remain deeply defensive, and the stock has now shed 23% over the past month to close at $146.19.
The positioning story has shifted materially from a week ago. Short interest climbed 8.9% on the week to 11.8% of free float — reversing the easing trend flagged in the prior note, when shorts had pulled back to around 10.8%. That prior decline looked like short-sellers taking profits into weakness; the rebound suggests fresh conviction. Over the past month, SI has grown 5.3%, and at roughly 26.9 million shares short, the position is the heaviest it has been in the 30-day window. The borrow market, however, is not flashing distress. Cost to borrow is just 0.43%, down 8% on the week, and availability is running at 309% — more than three shares available to lend for every one already borrowed. At that level, the lending pool offers no friction to new short-sellers, which is consistent with the SI build.
Options tell the same cautious story, though the most acute panic from the prior note has marginally eased. The put/call ratio ended the week at 0.87, still nearly 2.9 standard deviations above its 20-day mean of 0.74 and close to the 52-week high of 0.90. A week ago that z-score was above 3.6; the ratio has come off its intraday peak but remains at a level that signals meaningful demand for downside protection. Taken together with the short-interest rebuild, the picture is one of investors actively adding bearish exposure rather than simply holding existing hedges.
The Street has not followed that bearishness — at least not in ratings. Multiple analysts reiterated Buy-equivalent calls in mid-June at targets ranging from $220 to $280, and the consensus mean price target of $229 implies roughly 56% upside from current levels. The neutral camp, led by Baird, is more circumspect: Baird trimmed its target to $142 in early June, essentially in line with where the stock now trades. The factor picture adds nuance. The 30-day EPS momentum score is in the 96th percentile, reflecting a sharp upward revision cycle, but the 90-day momentum score sits at just the 4th percentile — the two readings point in opposite directions. EV/EBITDA has compressed to roughly 13.9x, down almost 1.4 turns over the past month as the stock fell, but a P/E still running near 50x leaves the valuation debate unresolved. The ORTEX short score has been drifting higher all week, closing at 58.3 — up from 55.3 ten days ago — ranking in the 12th percentile of the universe, which flags it as a name shorts are accumulating relative to peers.
The bull-bear divide maps cleanly onto the revenue concentration debate. Bulls point to the "super app" optionality — pre-IPO perpetuals, B2B partnerships, AI integration — and the ongoing profitability improvement. Bears focus on the structural vulnerability: transaction fees from retail crypto traders remain the dominant revenue source, and volumes compress fast when Bitcoin stalls. The stock's 7.6% weekly decline compares poorly against most correlated peers; HOOD dropped 2.9% and GEMI fell just 3.8%, while XXI and GLXY both shed more than 12% — suggesting the crypto-adjacent group is broadly under pressure, but Coinbase is tracking in the middle of that range rather than leading the selloff.
The next hard date is August 6, when Coinbase reports Q2 earnings. The two most recent prints produced a -2.8% next-day move and a +1.6% bounce respectively — a mixed reaction history that offers no clear lean. With short interest rebuilding, options skew still elevated, and the stock now more than 20% below its May peak, the Q2 print becomes less a referendum on whether Coinbase is growing and more a test of whether trading volumes held up through a volatile quarter — and whether management's diversification story has moved beyond talking points.
See the live data behind this article on ORTEX.
Open COIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
